Revolution Medicines, Inc. (RVMD)
Nasdaq: RVMD · CIK 0001628171 · United States
Every official Revolution Medicines, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RVMD filings
Revolution Medicines, Inc. documents
- Revolution Medicines, Inc. 10-K 2026RVMD 10-K 2026: annual report for fiscal 2026
- Revolution Medicines, Inc. 10-K 2025RVMD 10-K 2025: annual report for fiscal 2025
- Revolution Medicines, Inc. 10-K 2024RVMD 10-K 2024: annual report for fiscal 2024
- Revolution Medicines, Inc. 10-K 2023RVMD 10-K 2023: annual report for fiscal 2023
- Revolution Medicines, Inc. 10-K 2022RVMD 10-K 2022: annual report for fiscal 2022
- Revolution Medicines, Inc. 10-Q 2026RVMD 10-Q 2026: quarterly report for fiscal 2026
- Revolution Medicines, Inc. 10-Q 2025RVMD 10-Q 2025: quarterly report for fiscal 2025
- Revolution Medicines, Inc. 10-Q 2024RVMD 10-Q 2024: quarterly report for fiscal 2024
- Revolution Medicines, Inc. 10-Q 2023RVMD 10-Q 2023: quarterly report for fiscal 2023
- Revolution Medicines, Inc. 10-Q 2022RVMD 10-Q 2022: quarterly report for fiscal 2022
- Revolution Medicines, Inc. 8-K 2026RVMD 8-K 2026: current report for fiscal 2026
- Revolution Medicines, Inc. 8-K 2025RVMD 8-K 2025: current report for fiscal 2025
- Revolution Medicines, Inc. 8-K 2024RVMD 8-K 2024: current report for fiscal 2024
- Revolution Medicines, Inc. 8-K 2023RVMD 8-K 2023: current report for fiscal 2023
- Revolution Medicines, Inc. 8-K 2022RVMD 8-K 2022: current report for fiscal 2022
- Revolution Medicines, Inc. DEF 14A 2026RVMD DEF 14A 2026: proxy statement for fiscal 2026
- Revolution Medicines, Inc. DEF 14A 2025RVMD DEF 14A 2025: proxy statement for fiscal 2025
- Revolution Medicines, Inc. DEF 14A 2024RVMD DEF 14A 2024: proxy statement for fiscal 2024
- Revolution Medicines, Inc. DEF 14A 2023RVMD DEF 14A 2023: proxy statement for fiscal 2023
- Revolution Medicines, Inc. DEF 14A 2022RVMD DEF 14A 2022: proxy statement for fiscal 2022
- Revolution Medicines, Inc. Form 4 2026RVMD Form 4 2026: insider trading filing for fiscal 2026
- Revolution Medicines, Inc. Form 4 2025RVMD Form 4 2025: insider trading filing for fiscal 2025
- Revolution Medicines, Inc. Form 4 2024RVMD Form 4 2024: insider trading filing for fiscal 2024
- Revolution Medicines, Inc. Form 4 2023RVMD Form 4 2023: insider trading filing for fiscal 2023
- Revolution Medicines, Inc. Form 4 2022RVMD Form 4 2022: insider trading filing for fiscal 2022
- Revolution Medicines, Inc. S-1 2026RVMD S-1 2026: registration statement for fiscal 2026
- Revolution Medicines, Inc. S-1 2025RVMD S-1 2025: registration statement for fiscal 2025
- Revolution Medicines, Inc. S-1 2024RVMD S-1 2024: registration statement for fiscal 2024
- Revolution Medicines, Inc. S-1 2023RVMD S-1 2023: registration statement for fiscal 2023
- Revolution Medicines, Inc. S-1 2022RVMD S-1 2022: registration statement for fiscal 2022
- Revolution Medicines, Inc. 13F 2026RVMD 13F 2026: institutional holdings for fiscal 2026
- Revolution Medicines, Inc. 13F 2025RVMD 13F 2025: institutional holdings for fiscal 2025
- Revolution Medicines, Inc. 13F 2024RVMD 13F 2024: institutional holdings for fiscal 2024
- Revolution Medicines, Inc. 13F 2023RVMD 13F 2023: institutional holdings for fiscal 2023
- Revolution Medicines, Inc. 13F 2022RVMD 13F 2022: institutional holdings for fiscal 2022
More companies